EFFECT OF FOOD ON PHARMACOKINETICS AND SAFETY OF DA-8010, A NOVEL SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS

被引：0
|
作者：
Khwarg, J. [1 ]
Yang, E. [1 ]
Chung, W. [1 ]
Park, S. [1 ]
Jang, I [1 ]
Cho, J. [1 ]
Ryu, C. [2 ]
Lee, D. [2 ]
Lee, M. [2 ]
Kim, H. [3 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea
[2] Dong A ST Res Inst, Yongin, South Korea
[3] Dong A ST Co Ltd, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 78卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
31
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [41] Safety, pharmacokinetics, and food effect of sudapyridine (WX-081), a novel anti-tuberculosis candidate in healthy Chinese subjects
    Yu, Chengyin
    Qian, Hongjie
    Wu, Qingqing
    Zou, Yang
    Ding, Qicheng
    Cai, Yuting
    Liang, Liyu
    Xu, Juncai
    Li, Lei
    Zan, Bin
    Li, Yongguo
    Liu, Yun
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (02):
  • [42] Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
    Yang, Ling
    Shen, Qi
    Hu, Chao
    Wang, Ying
    Zhu, Xiaohong
    Shu, Shiqing
    Luo, Zhu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 3865 - 3876
  • [43] The pharmacokinetics and tolerability of telcagepant, a novel calcitonin gene related peptide (CGRP) receptor antagonist, in healthy subjects and migraineurs
    Han, T. H.
    Blanchard, R. L.
    Palcza, J.
    De Lepeleire, I
    Laethem, T.
    Martucci, A.
    Willson, K.
    Xu, Y.
    Boyle, J.
    Butterfield, K.
    Mahon, C.
    Ermlich, S.
    Matthews, C.
    Xiao, A. J.
    de Hoon, J. N.
    Gutierrez, M.
    Van Bortel, L.
    Bieberdorf, F. A.
    Van Hecken, A.
    Depre, M.
    Sinclair, S.
    Panebianco, D.
    Murphy, G.
    CEPHALALGIA, 2009, 29 : 12 - 12
  • [44] Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
    Shin, Dongseong
    Lee, SeungHwan
    Yi, Sojeong
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Bahng, Mi Young
    Jang, In-Jin
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 713 - 723
  • [45] The Effects of Alcohol on the Pharmacokinetics and Pharmacodynamics of the Selective Mu-Opioid Receptor Antagonist GSK1521498 in Healthy Subjects
    Ziauddeen, Hisham
    Nathan, Pradeep J.
    Dodds, Chris
    Maltby, Kay
    Miller, Sam R.
    Waterworth, Dawn
    Song, Kijoung
    Warren, Liling
    Hosking, Louise
    Zucchetto, Mauro
    Bush, Mark
    Johnson, Lakshmi Vasist
    Sarai, Bhopinder
    Mogg, Karin
    Bradley, Brendan P.
    Richards, Duncan B.
    Fletcher, Paul C.
    Bullmore, Edward T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (10): : 1078 - 1090
  • [46] Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies
    Tachibana, Masaya
    Matsuki, Shunji
    Toyama, Kaoru
    Maekawa, Yutaro
    Fukae, Masato
    Shimizu, Takako
    Tsutsumi, Junko
    Shinohara, Sayaka
    Ishizuka, Hitoshi
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (01): : 77 - 86
  • [47] Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects
    Khosravan, Reza
    Grabowski, Brian
    Wu, Jing-Tao
    Joseph-Ridge, Nancy
    Vernillet, Laurent
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (03) : 355 - 363
  • [48] Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects
    Xie, Ran
    Zhang, Yang
    Zhao, Nan
    Zhou, Shuang
    Wang, Xin
    Han, Wei
    Yu, Yan
    Zhao, Xia
    Cui, Yimin
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (03) : 353 - 360
  • [49] Combination of the angiotensin II-receptor antagonist olmesartan medoxomil with amlodipine: Pharmacokinetics, safety and tolerability in healthy male subjects
    Rump, LC
    Sellin, L
    Laeis, P
    JOURNAL OF HYPERTENSION, 2004, 22 : S145 - S145
  • [50] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of macitentan, an Endothelin Receptor Antagonist, in an Ascending Multiple-Dose Study in Healthy Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1131 - 1138
12345